Test Price
2,800 AEDโ Home Collection Available
GYG1 Gene Glycogen Storage Disease Type 15 (GSD15) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance by Certified Genetic Counselors.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The GYG1 gene NGS test screens for pathogenic variants causing Glycogen Storage Disease Type 15 (GSD15), a rare inborn error of glycogen metabolism that primarily affects muscle and cardiac tissue. This test employs high-coverage Next Generation Sequencing to detect single nucleotide variants, small indels, and copy number variations across all coding exons and flanking intronic regions.
Our Test vs. Closest Alternative
| Feature | Our GYG1 NGS Panel | Single-Gene Sanger Sequencing |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity for SNVs/indels, CNV detection | >99% for SNVs only; limited CNV detection |
| Method | NGS (Next Generation Sequencing) with high-depth coverage | Sanger sequencing (bidirectional) |
| Speed | 3โ4 Weeks (comprehensive analysis) | 6โ8 Weeks (serial exon sequencing) |
Physician Insight & Safety Protocols
โAs a clinical geneticist, I confirm that this NGS test provides definitive molecular diagnosis for GSD15. However, interpretation requires correlation with metabolic biomarkers, cardiac imaging, and family pedigree. A negative result does not rule out other glycogenoses or mitochondrial myopathies. Multidisciplinary management with a metabolic specialist remains essential.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
Advisory: Medication and Clinical Management
โ Do not alter or discontinue any prescribed medications, especially those for hypoglycemia prevention or metabolic crisis, without consulting your treating physician. This test provides diagnostic clarity and does not replace ongoing clinical care.
Exclusion Criteria & Red Flags
- Exclusion Criteria: Patients unable to provide valid informed consent (for minors, legal guardian must consent per Federal Decree-Law No. 4 of 2016 on Medical Liability). Individuals with active coagulopathy where venipuncture poses excessive risk.
- Emergency Red Flags: Acute metabolic decompensation (severe hypoglycemia, lactic acidosis, rhabdomyolysis, altered consciousness) requires immediate hospital careโdo not rely on home testing. Proceed directly to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the GYG1 gene test, and what condition does it detect?
The GYG1 genetic test uses next-generation sequencing to detect DNA mutations causing glycogen storage disease type 15, a rare inherited metabolic disorder that leads to abnormal glycogen accumulation in muscles and the heart, often presenting with exercise intolerance and cardiac dysfunction.
2. How is the sample collected and what is the turnaround time?
A blood sample (venous or finger-prick via FTA card) or buccal swab is collected by our VIP mobile phlebotomist at your home, office, or hotel. Results are available within 3 to 4 weeks after the laboratory receives the sample. Home collection is available daily from 8 AM to 11 PM with temperature-controlled cold-chain transport.
3. Is this test covered by health insurance plans in the UAE?
Many UAE insurance policies cover genetic testing for metabolic disorders when medically indicated. We offer direct billing verification via WhatsApp at +971 54 548 8731โsimply send a copy of your Emirates ID and insurance card for an instant eligibility check.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Security
All genetic data is processed and stored in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genomic information is encrypted end-to-end and accessed only by authorized medical personnel. Patient consent and medical liability follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | GYG1 Gene Glycogen Storage Disease Type 15 (GSD15) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Blood, dried blood spot (FTA card), or buccal swab |
| Methodology Used | Next Generation Sequencing (NGS) โ Whole gene sequencing including CNV detection |
| ICD-10-CM Code | E74.09 (Other glycogen storage disease) |
| LOINC Code | 78013-9 (DNA sequence analysis for specific gene mutation) |
| DHA Facility License & Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians